News
Baltimore played a role in virtually every important national debate over the use and potential misuse of the science of ...
9d
Interesting Engineering on MSNThe dark genome: why LINE-1 might be the key to cancer and aging
Also, subscribe to IE+ for premium insights and exclusive content! “There are half a million LINE-1 elements in your ...
PrEP reduces the risk of HIV, but current options need to be taken either daily in pill form or through an injection by a ...
RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, ...
An experimental antibody drug being developed by Jasper Therapeutics in a small early-stage trial allowed children who needed ...
Clin Drug Invest. 2007;27(8):509-531. Antiretroviral drugs (ARVs) can be divided into four different classes according to their modes of action: nucleoside or nucleotide reverse transcriptase ...
In this issue of hLife, the team led by Prof. Min Wang from Ocean University of China systematically mined and characterized the diversity of viral reverse transcriptases from global metagenomic ...
"We need to continue learning more about the different versions of reverse transcriptase at work in the aging and especially Alzheimer's disease brain," added Chun.
Read the latest data on resistance associated with reverse transcriptase inhibitors in these summaries from the 12th International HIV Drug Resistance Workshop.
New England Biolabs (NEB®) announced today that they have released a novel, thermostable reverse transcriptase, WarmStart® RTx Reverse Transcriptase, specifically designed for nucleic acid detection.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results